Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease: A prospective study in more than 100 patients

European Journal of Clinical Investigation

Volumn 31, Issue 3, 2001, Pages 240-247

  Muller P ^a   Ostwald, C ^a   Puschel K ^a   Brinkmann, B ^a   Plath, F ^a   Kroger J ^a   Barten, M ^a   Nizze, H ^a   Schareck, W D ^a   Hauenstein, K ^a   Liebe, S ^a   Lohr J M ^a,b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bile; Cholangiocarcinoma; Gall stones; p53; PCR; Ras

Indexed keywords

PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BILE FLOW; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GALLSTONE; GENE FREQUENCY; GENE MUTATION; HEPATOBILIARY DISEASE; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; BILE; BILE DUCT NEOPLASMS; BILIARY TRACT DISEASES; CHOLANGIOCARCINOMA; CHOLELITHIASIS; FEMALE; GENES, P53; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER DISEASES; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 0035064101     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00800.x     Document Type: Article

References (53)

1. Comparison of flow cytometry for DNA content and brush cytology for detection of malignancy in pancreatobiliary strictures
2. Diagnostic p53 immunostaining of endobiliary brush cytology: Preoperative cytology compared with the surgical specimen
3. Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies
4. The pathobiology of biliary epithelia
5. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice
6. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma
7. Pancreatic cancer in Europe: Ki-ras mutation pattern shows geographical differences
8. p53 and k-ras alterations in pancreatic epithelial cell lesions
9. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor suppressor genes
10. p53 and ras mutations in pancreatic juice samples of patients with chronic pancreatitis
11. Restriktionsenzym-mismatch-polymerase-kettenreaktion zum nachweis von ki-ras-onkogen-mutationen beim pankreaskarzinom
12. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: Comparison with K-ras mutation
13. Degradation of decorin by matrix metalloproteinases: Identification of the cleavage sites, kinetic analyses and transforming growth factor-β1 release
14. Detection of ras gene mutation in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma
15. Detection of c-ki-ras point mutation from pancreatic juice
16. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: Correlation with tumor grade and survival
17. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis
18. Expression of p53 in adenocarcinoma of the gallbladder and in bile ducts
19. Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilatation
20. Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: Relation to gross tumor morphology
21. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
22. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers
23. HPV DNA and p53 alterations in oropharyngeal carcinomas
24. Simple method for DNA extraction from pancreatic juice for PCR amplification assays
25. Modification of enzymatically amplified DNA for the detection of point mutations
26. Infrequent mutation in tumor suppressor gene p53 in gestational trophoblastic neoplasia
27. Accumulation of wild-type p53 protein in progressive multifocal leukoencephalopathy: A flow cytometry and DNA sequencing study
28. Rapid screening for Tp53 mutations by temperature gradient gel electrophoresis: A comparison with SSCP analysis
29. Analysis of k-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease
30. Usefulness of k-ras gene mutation at codon 12 in bile for diagnosing biliary strictures
31. Detection of mutated c-ki-ras in the bile of patients with pancreatic cancer
32. Detection of Ki-ras gene point mutations in bile specimens for the differential diagnosis of malignant and benign biliary strictures
33. Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer
34. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand
35. High rates of ki-ras point mutations in both intra- and extra-hepatic cholangiocarcinomas
36. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis
37. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers
38. Diagnostic and prognostic value of incidence of kras codon 12 mutations in resected distal bile duct carcinoma
39. K-ras gene mutation in gall bladder carcinomas and dysplasia
40. Proliferative potential and k-ras mutation in epithelial hyperplasia of the gallbladder in patients with and without anomalous pancreaticobiliary ductal union
41. Detection of point mutations in k-ras gene at codon 12 in bile from percutaneous transhepatic choledochal drainage tubes for diagnosis of biliary strictures
42. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction
43. K-ras mutation: Early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers - A review
44. K-ras mutations and benign pancreatic disease
45. An immunohistochemical study of p53 protein in gall bladder and extrahepatic bile duct/ampullary carcinomas
46. Prognostic significance of molecular alterations in human pancreatic carcinoma - An immunohistological study
47. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: Loss of intranuclear expression
48. The k-ras mutation pattern in pancreatic ductal adenocarcinoma is usually identical to that in associated normal, hyperplastic and metaplastic duct epithelium
49. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases
50. Quantitative analysis of ras gene mutation in pancreatic juice for diagnosis of pancreatic adenocarcinoma
51. Pancreatitis and the risk of pancreatic cancer
52. Analysis of k-ras oncogene mutation directly applied to atypical cell clusters on cytologic smear slides of bile and pancreatic juice